About

Find a Practitioner

Education

Research

Resources

A Fresh Approach to Fighting Glioblastoma: Starving the Enemy Within

Chris Joseph
on
Monday, January 27, 2025
A Fresh Approach to Fighting Glioblastoma: Starving the Enemy Within

Glioblastoma, one of the most aggressive brain cancers, has been leaving patients and doctors feeling frustrated for decades. Despite all our medical advancements, the prognosis for glioblastoma hasn’t budged much—most patients live only 14–21 months after diagnosis. Even with surgery, chemotherapy, and radiation, long-term survival is incredibly rare. So, researchers are looking for new ways to tackle this stubborn cancer. This study offers a bold new strategy: instead of fighting cancer head-on, why not cut off its fuel supply?

The paper, titled "Clinical Research Framework Proposal for Ketogenic Metabolic Therapy in Glioblastoma," which was co-authored by Dr. Ahmed Elsakka, MTIH Director of Clinical Research, explores how a combination of diet, fasting, and drugs might slow down glioblastoma by targeting the way cancer cells get their energy. You can find the original study here.

The Problem with Glioblastoma

Glioblastoma is a fast-growing, relentless type of brain tumor. It’s especially deadly because it has a way of finding workarounds to survive treatments. Surgery can’t always remove every bit of the tumor, radiation only provides temporary control, and chemotherapy often stops working because the cancer adapts. The tumor grows back quickly, and when it does, it’s usually even harder to treat.

What makes glioblastoma so tricky? It has unique needs for energy. Cancer cells, including glioblastoma, rely heavily on two fuels: sugar (glucose) and glutamine, an amino acid. Unlike normal cells, which can adapt to using different types of energy sources like fats or ketones, glioblastoma cells are stuck in a sugar-and-glutamine rut. They need these two fuels to keep multiplying and spreading. This dependency might be their Achilles’ heel.

The Ketogenic Solution

This study proposes a new way of fighting glioblastoma called ketogenic metabolic therapy (KMT). It’s based on a simple idea: if cancer thrives on sugar and glutamine, why not take them away?

A ketogenic diet is very low in carbohydrates (which the body turns into sugar), moderate in protein, and high in fat. It forces the body to switch to burning fat for fuel, producing substances called ketones. Ketones are a great energy source for normal cells but not for cancer cells—they simply can’t use ketones to grow and divide.

The researchers argue that combining this diet with drugs and fasting could create a “perfect storm” for glioblastoma. Here’s how it works:

  1. Starving the cancer: The ketogenic diet cuts off sugar, and drugs can block the tumor’s use of glutamine. Without its two main energy sources, the cancer struggles to survive.

  2. Boosting healthy cells: Normal cells thrive on ketones and can stay strong even when glucose levels are low.

  3. Shrinking the tumor’s defenses: This approach may also reduce inflammation and change the tumor’s environment, making it harder for cancer cells to thrive.

More Than Just a Diet

The study makes it clear: this isn’t just about eating a high-fat diet. Ketogenic metabolic therapy is a comprehensive strategy that includes:

  • Fasting or calorie restriction: Periods of fasting can put extra pressure on cancer cells while giving healthy cells a chance to recover.

  • Medications: Specific drugs can block the ways cancer cells use sugar and glutamine.

  • Monitoring and adjustment: Patients would need regular checks to make sure their blood sugar and ketone levels are in the right range.

This isn’t a “one-size-fits-all” solution. It’s more like a carefully coordinated dance between diet, medicine, and lifestyle changes.

Why This Works

The idea behind KMT isn’t entirely new. It builds on decades of research into how cancer cells work. Back in the 1920s, a scientist named Otto Warburg discovered that cancer cells rely on a process called fermentation to make energy, even when oxygen is available. This is different from normal cells, which prefer to use oxygen to produce energy efficiently. Glioblastoma cells, like most cancer cells, are addicted to this fermentation process, which depends heavily on sugar and glutamine.

The study also highlights how ketogenic diets have been used successfully in other medical conditions, like epilepsy. These diets can reduce inflammation, protect healthy cells, and improve overall energy balance—all things that could help in the fight against cancer.

Early Evidence and Challenges

The good news is that early studies on ketogenic diets in cancer show promise. Patients report feeling better, with less fatigue and improved quality of life. Animal studies suggest that combining a ketogenic diet with other treatments can slow tumor growth. However, there’s still a lot we don’t know. For example:

  • How low do blood sugar and glutamine levels need to be to make a real difference?

  • What’s the best way to combine diet, fasting, and drugs?

  • Are there any long-term risks of staying in a ketogenic state?

The study emphasizes that more clinical trials are needed to answer these questions. Right now, over 60 trials are underway to explore the potential of ketogenic diets in various types of cancer, including glioblastoma.

The Bigger Picture

One of the most exciting aspects of this approach is that it shifts the focus from “destroying” cancer to outsmarting it. Traditional treatments like chemo and radiation often cause collateral damage, harming healthy cells along with the tumor. KMT, on the other hand, works by taking advantage of the unique vulnerabilities of cancer cells.

This strategy could also be a game-changer for other cancers that rely heavily on sugar and glutamine. The researchers hope their framework will inspire more studies and eventually lead to new guidelines for cancer care.

A Message of Hope

Glioblastoma may be one of the toughest cancers out there, but this study offers more than a glimmer of hope. By understanding how cancer cells live and grow, we can find smarter ways to stop them.

For more details, you can read the full study here.

Summarized by:
Chris Joseph
Certified Terrain Advocate with the Metabolic Terrain Institute of Health
chris@terrainnavigators.com

Connect with the Metabolic Terrain Institute of Health